Basaran, G. Et Al. 2018. Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. CANCER TREATMENT REVIEWS , vol.63 , 144-155.

Basaran, G., Twelves, C., Dieras, V., Cortes, J., & Awada, A., (2018). Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. CANCER TREATMENT REVIEWS , vol.63, 144-155.

Basaran, Gül Et Al. "Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer," CANCER TREATMENT REVIEWS , vol.63, 144-155, 2018

Basaran, Gül Et Al. "Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer." CANCER TREATMENT REVIEWS , vol.63, pp.144-155, 2018

Basaran, G. Et Al. (2018) . "Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer." CANCER TREATMENT REVIEWS , vol.63, pp.144-155.

@article{article, author={Gül BAŞARAN Et Al. }, title={Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer}, journal={CANCER TREATMENT REVIEWS}, year=2018, pages={144-155} }